3M reported a strong third quarter with record sales of $6.2 billion and increased earnings guidance, driven by robust growth in international markets and the healthcare segment. While there are some concerns in U.S. end-markets, the overall positive financial performance and strategic investments are likely to bolster investor confidence in the short term.

[1]